Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-22

Study Completion Date

2021-11-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that are consistent with early signs of SARS-CoV-2 infection in this high-risk population by automatically (and securely) transferring this information to health care providers. The primary aim of this study is to determine the feasibility, ease of use, and perceived utility of this app to monitor symptoms and health risk behaviors among cancer patients currently receiving chemotherapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic

NCT04464486

Oncology

COMPLETED NA

Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer

NCT02157519

Adherence to Medication Regime Cancer

COMPLETED NA

Electronic Patient Reporting of Symptoms During Cancer Treatment

NCT03249090

Metastatic Cancer

COMPLETED NA

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

NCT07291414

Breast Carcinoma Colorectal Carcinoma Lung Carcinoma +2 more

RECRUITING NA

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

NCT06860425

Mobile Applications Cancer Patients

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 500 treatment-seeking males and females will be asked to complete daily monitoring of symptoms via smartphone app. Those who screen positive for COVID-19 will be triaged to emergency or non-emergency medical treatment and will receive a study supplied device to measure their oxygen level and heart rate and be instructed in the device's use. They will be prompted to enter vital signs data (such as oxygen level) daily (and as indicated by changes in status) and questions from the app will change to assess the severity of COVID-19 related symptoms and inform changes in level of care, to emergency or non-emergency medical management as indicated by self-reporting. The proposed study will assess the impact of heightened symptom and vital sign monitoring on the early identification of severe manifestations of COVID-19 in this high-risk population (Aim 2). It is hypothesized that this will significantly improve COVID-19 related morbidity and mortality compared to the national and international rates currently reported in the literature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sars-CoV2 Covid-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Elevated Risk for COVID-19 Detected

Continue daily mHealth assessments

Group Type EXPERIMENTAL

mHealth Assessments

Intervention Type OTHER

Daily symptom tracker

Elevated Risk for COVID-19 Detected

Daily mHealth assessments and telemedicine/nurse triage. If non-emergent intervention, enhanced symptom monitoring will occur.

Group Type EXPERIMENTAL

mHealth Assessments

Intervention Type OTHER

Daily symptom tracker

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mHealth Assessments

Daily symptom tracker

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Demonstrate \> 6th grade English literacy level (i.e., phone based EMAs require \>6th grade literacy)
2. Present for care at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center
3. Are currently receiving systemic chemotherapy by intravenous infusion or by orally delivered medication
4. Are greater than or equal to 18 years of age
5. Are willing and able to complete surveys on their personal smartphone or a study provided smartphone
6. Are willing and able to provide informed consent